EODData

NASDAQ, PRME: Prime Medicine Inc

30 Dec 25 15:59
LAST:

3.430

CHANGE:
 0.07
OPEN:
3.370
HIGH:
3.510
ASK:
0.000
VOLUME:
2.08M
CHG(%):
2.08
PREV:
3.370
LOW:
3.340
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
30 Dec 253.3703.5103.3403.4402.5M
29 Dec 253.4503.5103.3303.3702.92M
26 Dec 253.5703.5903.4653.5002.59M
24 Dec 253.6603.6603.5103.5702.29M
23 Dec 253.7203.7853.6203.6902.29M
22 Dec 253.7403.8363.6103.7002.61M
19 Dec 253.6403.8503.6103.64016.4M
18 Dec 253.8504.0103.5903.6003.76M
17 Dec 253.9404.1203.7203.7402.32M
16 Dec 253.9604.1003.8203.8803.22M

PROFILE

Name:Prime Medicine Inc
About:Prime Medicine, Inc., a biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States. It offers Prime Editing technology comprising a programmable DNA binding domains, such as Cas domains, are typically modified such that they do not cause a double-stranded break in the DNA, as well as a RT domain that copies the edited DNA sequence directly into the target genomic site where the edit is made; and pegRNA which contains a search sequence, also known as a spacer, which provides a target genomic address for the Prime Editor. The company has a research collaboration with Cimeio Therapeutics to develop Prime Edited Shielded-Cell & Immunotherapy Pairs for genetic diseases, acute myeloid leukemia, and myelodysplastic syndrome. Prime Medicine, Inc. was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:60 First Street, Cambridge, MA, United States, 02141
Website:https://primemedicine.com
CUSIP:74168J101
CIK:0001894562
ISIN:US74168J1016
FIGI:BBG011RT3R55

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-2.76 
Forward P/E:-3.50 
PEG Ratio:0.25 
Price to Sales:177.52 
Price to Book:10.62 
Operating Margin:-47.87 
Return on Assets:-0.47 
Return on Equity:-1.55 
EPS Ratio:-1.56 
Revenue:4.96M 
Shares:178.27M 
Market Cap:611.48M 

TECHNICAL INDICATORS

MA5:3.512.4%
MA10:3.615.3%
MA20:3.7910.5%
MA50:4.0618.4%
MA100:4.3125.7%
MA200:3.294.3%
STO9:9.33 
STO14:6.67 
RSI14:22.63 
WPR14:-92.71 
MTM14:-0.89
ROC14:-0.21 
ATR:0.26 
Week High:3.7910.3%
Week Low:3.333.0%
Month High:4.4228.9%
Month Low:3.264.3%
Year High:6.94102.3%
Year Low:1.11209.0%
Volatility:33.67